Predictive Score for Maxillary Osteonecrosis After Invasive Oral Surgery (PREV-ONM)
Development of a Predictive Score for Maxillary Osteochimionecrosis After Invasive Oral Surgery in Patients Treated Whith Biphosphonates or Biotherapies: the PREV-ONM Study
Sponsor: Centre Hospitalier Sud Francilien
Terminated
rate of inclusions too low
Other terminated trials from Centre Hospitalier Sud Francilien
A observational or N/A phase clinical study on Osteonecrosis Due to Drugs, Jaw, this trial is terminated or withdrawn. The trial is conducted by Centre Hospitalier Sud Francilien and has accumulated 8 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Dec 2024 — Present [monthly]
Terminated
-
Sep 2024 — Dec 2024 [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
May 2022 — Jul 2024 [monthly]
Terminated
Status: Recruiting → Terminated
-
Jun 2021 — May 2022 [monthly]
Recruiting
▶ Show 3 earlier versions
-
Jan 2021 — Jun 2021 [monthly]
Recruiting
-
Jul 2020 — Jan 2021 [monthly]
Recruiting
-
Mar 2020 — Jul 2020 [monthly]
Recruiting
First recorded
Oct 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Hospitalier Sud Francilien
For direct contact, visit the study record on ClinicalTrials.gov .